United States · FDA National Drug Code directory
REGOXIDINE (FOR WOMEN)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57483-175_40d86d45-ccc6-4b7e-a152-453469b21379
- Product NDC
- 57483-175
- Form
- AEROSOL, FOAM
- Composition / generic term
- MINOXIDIL
- Labeler
- INNOVUS PHARMACEUTICALS, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250503
- Source listing expiry
- 20271231
Source-listed ingredients
- MINOXIDIL — 50 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CAN in 1 CARTON (57483-175-11) / 60 g in 1 CAN (57483-175-01) · 57483-175-11
- 2 CAN in 1 CARTON (57483-175-12) / 60 g in 1 CAN (57483-175-01) · 57483-175-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →